Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

Recent research has revealed compelling evidence supporting tenecteplase as a more effective treatment for ischemic strokes compared to traditional alteplase therapy. This discovery could mark a major ...

For more than 40 years as a researcher and clinician, Joseph Broderick has actively contributed to improvements in stroke care, occupying a front row seat to seismic innovations: the clinical trials ...

A streamlined, nurse-led response for hospitalized patients experiencing an acute stroke at a Texas academic medical center improved time from symptom discovery to imaging and treatment, which is ...

Although stroke treatments have vastly improved in recent years, leading to better outcomes for many, one population of patients often does not receive these effective therapies: those who suffer ...

American Stroke Association International Stroke Conference 2026 annual awards go to 11 stroke researchers for science, brain health contributions.